AKT1 and hepatocellular carcinoma: Additional human studies highlighted the role of H3K4me3-mediated S1PR1 expression in activating downstream oncogenic signaling pathways such as PI3K-Akt, JAK-STAT, and MAPK signaling, culminating in enhanced HCC proliferation, metastasis, and reduced survival [59].